AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimsafe MF 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Beats Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimsafe MF 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor; lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and treatment. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician prior to use. Pregnant or lactating women require medical consultation before commencing treatment. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your doctor.

Primary Ingredients of Glimsafe MF 1mg/500mg Tablet

The information is unavailable.

Uses of Glimsafe MF 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimsafe MF 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimsafe MF 1mg/500mg tablets should be administered with a meal.

Common Side effects of Glimsafe MF 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimsafe MF 1mg/500mg Tablet:

Consume Glimsafe MF 1mg/500mg tablets precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Food should accompany each dose.

How Glimsafe MF 1mg/500mg Tablet works:

Glimepiride/Metformin 1mg/500mg (Glimsafe MF) tablets combine two distinct antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts threefold: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimsafe MF 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimsafe MF 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Glimsafe MF 1mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates a potential risk of infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimsafe MF 1mg/500mg tablets, potentially requiring dosage modification. Medical consultation is recommended. The use of Glimsafe MF 1mg/500mg tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimsafe MF 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For individuals with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimsafe MF 1mg/500mg Tablet :

Should you forget a Glimsafe MF 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glimsafe MF 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimsafe MF 1mg/500mg Tablet

Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Glimsafe MF 1mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful adverse effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, and bradycardia. If such symptoms develop, discontinue Glimsafe MF 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimsafe MF 1mg/500mg Tablet, treat type 2 diabetes mellitus (DM) in adults. This dual-action medication enhances blood glucose control when used with a balanced diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas to reduce blood glucose, while Metformin decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for managing type 1 DM.
Glimsafe MF 1mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged Glimsafe MF 1mg/500mg Tablet consumption can indeed lead to Vitamin B12 deficiency. This is due to the medication's impact on Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some researchers include annual supplemental Vitamin B12 intake.
Glimsafe MF 1mg/500mg Tablets may induce hypoglycemia (low blood sugar). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimsafe MF 1mg/500mg tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Concurrent use also elevates the likelihood of lactic acidosis.
Glimsafe MF 1mg/500mg Tab...
45
MRP 55
18% off